Ryota Usui, Daisuke Yabe, Muhammad Fauzi, Hisanori Goto, Ainur Botagarova, Shinsuke Tokumoto, Hisato Tatsuoka, Yumiko Tahara, Shizuka Kobayashi, Toshiya Manabe, Yoshihiro Baba, Tomohiro Kurosaki, Pedro Luis Herrera, Masahito Ogura, Kazuaki Nagashima, Nobuya Inagaki |
Usui R, Yabe D, Fauzi M, Goto H, Botagarova A, Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera PL, Ogura M, Nagashima K, Inagaki N |
Ryota Usui, Daisuke Yabe, Muhammad Fauzi, Hisanori Goto, Ainur Botagarova, Shinsuke Tokumoto, Hisato Tatsuoka, Yumiko Tahara, Shizuka Kobayashi, Toshiya Manabe, Yoshihiro Baba, Tomohiro Kurosaki, Pedro Luis Herrera, Masahito Ogura, Kazuaki Nagashima, Nobuya Inagaki |
GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.  |
GPR40 activation initiates store-operated Ca<sup>2+</sup> entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.  |
GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.  |
Scientific reports, 9, 1, 15562-15562 |
Scientific reports, 9, 1, 15562-15562 |
Scientific reports, 9, 1, 15562-15562 |
2019/10/29 |
Refereed |
English |
|
Disclose to all |
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N |
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N |
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N |
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. |
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. |
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. |
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR |
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR |
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR |
2019/02 |
Refereed |
|
|
Disclose to all |
Ryota Usui, Daisuke Yabe, Yutaka Seino |
Ryota Usui, Daisuke Yabe, Yutaka Seino |
Ryota Usui, Daisuke Yabe, Yutaka Seino |
Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity |
Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity |
Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity |
Journal of Diabetes Investigation |
Journal of Diabetes Investigation |
Journal of Diabetes Investigation |
2019/02 |
Refereed |
|
|
Disclose to all |
Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D |
Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D |
Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D |
Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes |
Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes |
Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes |
J Diabetes Investig, 9, 5, 1153-1158 |
J Diabetes Investig, 9, 5, 1153-1158 |
J Diabetes Investig, 9, 5, 1153-1158 |
2018/09 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes. |
Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes. |
Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes. |
Journal of diabetes investigation, 9, 5, 1153-1158 |
Journal of diabetes investigation, 9, 5, 1153-1158 |
Journal of diabetes investigation, 9, 5, 1153-1158 |
2018/09 |
Refereed |
English |
|
Disclose to all |
Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D |
Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D |
Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D |
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation.  |
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation.  |
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation.  |
J Diabetes Investig, 9, 4, 822-830 |
J Diabetes Investig, 9, 4, 822-830 |
J Diabetes Investig, 9, 4, 822-830 |
2018/07 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Usui R, Sakuramachi Y, Seino Y, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Y, Yabe D |
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.  |
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation  |
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.  |
Journal of diabetes investigation, 9, 4, 822-830 |
Journal of Diabetes Investigation, 9, 4, 822-830 |
Journal of diabetes investigation, 9, 4, 822-830 |
2018/07 |
Refereed |
English |
|
Disclose to all |
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.  |
Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after init  |
Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.  |
Journal of diabetes investigation, 9, 4, 981-983 |
Journal of Diabetes Investigation, 9, 4, 981-983 |
Journal of diabetes investigation, 9, 4, 981-983 |
2018/07 |
Refereed |
English |
|
Disclose to all |
Yu Wang, Shin-ichi Harashima, Yanyan Liu, Ryota Usui, Nobuya Inagaki |
Yu Wang, Shin-ichi Harashima, Yanyan Liu, Ryota Usui, Nobuya Inagaki |
Yu Wang, Shin-ichi Harashima, Yanyan Liu, Ryota Usui, Nobuya Inagaki |
Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion  |
Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion  |
Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion  |
SCIENTIFIC REPORTS, 7, 1 |
SCIENTIFIC REPORTS, 7, 1 |
SCIENTIFIC REPORTS, 7, 1 |
2017/04 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima |
Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima |
Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima |
Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice  |
Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice  |
Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice  |
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865 |
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865 |
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865 |
2016/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Hiroki Sato, Kazuaki Nagashima, Masahito Ogura, Yuichi Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki |
Sato H, Nagashima K, Ogura M, Sato Y, Tahara Y, Ogura K, Yamano G, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N |
Hiroki Sato, Kazuaki Nagashima, Masahito Ogura, Yuichi Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki |
Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic -cells  |
Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic β-cells  |
Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic -cells  |
JOURNAL OF DIABETES INVESTIGATION, 7, 2, 171-178 |
Journal of Diabetes Investigation, 7, 2, 171-178 |
JOURNAL OF DIABETES INVESTIGATION, 7, 2, 171-178 |
2016/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Kenta Murotani, Takeshi Kurose, Yutaka Seino |
Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y |
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Kenta Murotani, Takeshi Kurose, Yutaka Seino |
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining beta-cell function and achievement of HbA1c target one year after initiation |
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation |
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining beta-cell function and achievement of HbA1c target one year after initiation |
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 29, 8, 1203-1210 |
Journal of Diabetes and its Complications, 29, 8, 1203-1210 |
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 29, 8, 1203-1210 |
2015/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Daisuke Yabe, Hitoshi Kuwata, Ryota Usui, Takeshi Kurose, Yutaka Seino |
Daisuke Yabe, Hitoshi Kuwata, Ryota Usui, Takeshi Kurose, Yutaka Seino |
Daisuke Yabe, Hitoshi Kuwata, Ryota Usui, Takeshi Kurose, Yutaka Seino |
Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points |
Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points |
Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points |
CURRENT MEDICAL RESEARCH AND OPINION, 31, 7, 1267-1270 |
CURRENT MEDICAL RESEARCH AND OPINION, 31, 7, 1267-1270 |
CURRENT MEDICAL RESEARCH AND OPINION, 31, 7, 1267-1270 |
2015/07 |
Refereed |
English |
|
Disclose to all |
安原章浩, 臼井亮太, 岩崎真宏, 桑田仁司, 渡邊好胤, 表孝徳, 矢部大介, 北谷直美, 古宮俊幸, 黒瀬健 |
安原章浩, 臼井亮太, 岩崎真宏, 桑田仁司, 渡邊好胤, 表孝徳, 矢部大介, 北谷直美, 古宮俊幸, 黒瀬健 |
|
腎機能低下2型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討 |
腎機能低下2型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討 |
|
日本病態栄養学会学会誌, 17, 3, 367-375 |
日本病態栄養学会学会誌, 17, 3, 367-375 |
, 17, 3, 367-375 |
2014 |
Refereed |
|
|
Disclose to all |
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Akihiro Yasuhara, Masahiro Iwasaki, Naomi Kitatani, Kyoko Kuwabara, Kayo Yokota, Takeshi Kurose, Yutaka Seino |
Usui R, Yabe D, Kuwata H, Fujiwara S, Watanabe K, Hyo T, Yasuhara A, Iwasaki M, Kitatani N, Kuwabara K, Yokota K, Kurose T, Seino Y |
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Akihiro Yasuhara, Masahiro Iwasaki, Naomi Kitatani, Kyoko Kuwabara, Kayo Yokota, Takeshi Kurose, Yutaka Seino |
Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced beta-cell function |
Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function |
Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced beta-cell function |
JOURNAL OF DIABETES INVESTIGATION, 4, 6, 585-594 |
Journal of Diabetes Investigation, 4, 6, 585-594 |
JOURNAL OF DIABETES INVESTIGATION, 4, 6, 585-594 |
2013/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Daisuke Yabe, Mariyo Rokutan, Yoshiyuki Miura, Izumi Komoto, Ryota Usui, Hitoshi Kuwata, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Terumi Nagamatsu, Shinobu Shimizu, Jun Kawai, Masayuki Imamura, Yutaka Seino |
Yabe D, Rokutan M, Miura Y, Komoto I, Usui R, Kuwata H, Watanabe K, Hyo T, Kurose T, Nagamatsu T, Shimizu S, Kawai J, Imamura M, Seino Y |
Daisuke Yabe, Mariyo Rokutan, Yoshiyuki Miura, Izumi Komoto, Ryota Usui, Hitoshi Kuwata, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Terumi Nagamatsu, Shinobu Shimizu, Jun Kawai, Masayuki Imamura, Yutaka Seino |
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic alpha cells in vivo |
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo |
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic alpha cells in vivo |
DIABETES RESEARCH AND CLINICAL PRACTICE, 102, 1, E1-E4 |
Diabetes Research and Clinical Practice, 102, 1, E1-E4 |
DIABETES RESEARCH AND CLINICAL PRACTICE, 102, 1, E1-E4 |
2013/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y |
Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y |
Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y |
Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin |
Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin |
Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin |
Diabetes Therapy, 3, 1, 14 |
Diabetes Therapy, 3, 1, 14 |
Diabetes Therapy, 3, 1, 14 |
2012/12 |
Refereed |
|
|
Disclose to all |
Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji, Naoki Hirose, Tomoko Matsumoto, Naomi Kitatani, Kenji Sugawara, Ryota Usui, Hitoshi Kuwata, Kazu Sugizaki, Yuka Kitamoto, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji, Naoki Hirose, Tomoko Matsumoto, Naomi Kitatani, Kenji Sugawara, Ryota Usui, Hitoshi Kuwata, Kazu Sugizaki, Yuka Kitamoto, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Masahiro Iwasaki, Fuminori Hoshian, Tomoko Tsuji, Naoki Hirose, Tomoko Matsumoto, Naomi Kitatani, Kenji Sugawara, Ryota Usui, Hitoshi Kuwata, Kazu Sugizaki, Yuka Kitamoto, Shuichi Fujiwara, Koin Watanabe, Takanori Hyo, Takeshi Kurose, Yutaka Seino, Daisuke Yabe |
Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels |
Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels |
Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels |
JOURNAL OF DIABETES INVESTIGATION, 3, 5, 464-467 |
JOURNAL OF DIABETES INVESTIGATION, 3, 5, 464-467 |
JOURNAL OF DIABETES INVESTIGATION, 3, 5, 464-467 |
2012/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
六反麻里代, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 河合潤, 細田洋平, 粟根雅章, 滝吉郎, 舘秀和, 植田孔明, 水野浩, 黒瀬健, 清野裕 |
六反麻里代, 矢部大介, 臼井亮太, 菅原健二, 北本友佳, 桑田仁司, 杉崎和, 藤原周一, 渡邊好胤, 表孝徳, 河合潤, 細田洋平, 粟根雅章, 滝吉郎, 舘秀和, 植田孔明, 水野浩, 黒瀬健, 清野裕 |
|
HbA1c悪化と体重減少を契機に膵癌を含む重複癌が発見された2型糖尿病の一例 |
HbA1c悪化と体重減少を契機に膵癌を含む重複癌が発見された2型糖尿病の一例 |
|
糖尿病, 55, 7, 477-482 |
糖尿病, 55, 7, 477-482 |
, 55, 7, 477-482 |
2012 |
Refereed |
|
|
Disclose to all |
Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y |
Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y |
Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y |
A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control |
A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control |
A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control |
Journal of the Japan Diabetes Society, 55, 7, 477-482 |
Journal of the Japan Diabetes Society, 55, 7, 477-482 |
Journal of the Japan Diabetes Society, 55, 7, 477-482 |
2012 |
Refereed |
|
|
Disclose to all |